معرفی
Dr. Siamak Daneshmand is a Professor of Urology and Medicine (Oncology) at the Keck School of Medicine of USC, serving as Director of Urologic Oncology and Urologic Oncology Fellowship Director. His expertise includes bladder, testicular, and kidney cancers, with a focus on perioperative outcomes, molecular markers, and surgical techniques like nerve-sparing RPLND. He leads clinical trials (e.g., SEMS, SWOG) and chairs the SUO-CTC Bladder Section.
Research interests span bladder cancer pathways, biomarkers (e.g., miRNA, ctDNA), and functional outcomes post-cystectomy. He chairs AUA guidelines for bladder and testicular cancers and is an SWOG local bladder committee member.
Key articles focus on testicular cancer survivorship, novel therapies (TAR-200), bladder preservation strategies, and genomic classifiers. Over 400 peer-reviewed publications highlight his contributions to urologic oncology.
Scientific awards include 13 years as 'America’s Top Cancer Doctor' and Alpha Omega Alpha membership. He has led over a dozen clinical trials and serves on multiple steering committees.
